USA
Canada
Australia
New Zealand
Europe
UK / IRE
The CPMA would like to remind trainers, owners, veterinarians, and other stakeholders that the Elimination Guidelines (EG) for isoflupredone changed as of April 3, 2023. The change is detailed in the table below. Testing protocols for isoflupredone have been adjusted accordingly.
Only the EGs currently published on the CPMA’s website should be relied on when making treatment decisions for a racehorse.
The CPMA strongly recommends that you consult your veterinarian on any decision to administer supplements or medications to a racehorse.
If you have any questions, please contact the CPMA at 1-800-268-8835 or aafc.cpmawebacpm.aac@agr.gc.ca.
| Drug name | Previous elimination guideline | Current elimination guideline (effective April 3, 2023) | Rationale for change | ||||
| Isoflupredone | Intramuscular (IM)
48h / 24 mg IM / single |
Intra-articular (IA)
· 6 days / 10 mg IA / single |
The IM use is no longer recommended due to the variable and extended elimination of isoflupredone by this route. |
From the Canadian Pari-Mutuel Agency
